Glycogen Storage Disease Type III clinical trials at UC Irvine

1 research study open to eligible people

Safety, Tolerability, and Pharmacokinetics of UX053 in Patients With Glycogen Storage Disease Type III (GSD III)
open to eligible people ages 18 years and up
The primary objective of the study is to evaluate the safety of UX053 in adults with Glycogen Storage Disease Type III (GSD III).
Orange, California and other locations

Last updated: October 20, 2022